National Center for Advancing Translational Sciences
| Abbreviation | NCATS |
|---|---|
| Formation | 2011 |
| Type | U.S. government agency |
| Legal status | Active |
| Headquarters | Bethesda, Maryland |
Region served |
 United States |
Official language | English |
Director | Christopher P. Austin, M.D. |
Parent organization | National Institutes of Health |
| Affiliations | United States Public Health Service |
| Website |
http: |
The National Center for Advancing Translational Sciences (NCATS) was established in 2012[1] and is located in Bethesda, Maryland. The NCATS is one of 27 institutes and centers of the US National Institutes of Health (NIH), an agency of the US Department of Health and Human Services. The mission of NCATS is to transform the translation of scientific discoveries so that new treatments and cures for disease can be delivered to patients faster.
History
NCATS was created in December 2011 by the Consolidated Appropriations Act, 2012.[2]
The center was created from a number of existing NIH programs :[3]
- Clinical and Translational Science Award program,
- Components of the Molecular Libraries Program,
- Therapeutics for Rare and Neglected Diseases,
- RAID renamed Bridging Interventional Development Gaps
- Office of Rare Diseases Research,
- NIH–FDA Regulatory Science Initiative,
- Cures Acceleration Network (CAN) [4][5]
Organizational structure
- Office of the Director:
- Christopher P. Austin, M.D. (Director)
- Pamela M. McInnes, D.D.S. (Deputy Director)
- Executive Office
- Office of Grants Management and Scientific Review
- Office of Rare Diseases Research
- Office of Policy, Communications and Strategic Alliances
- Division of Pre-Clinical Innovation
- Division of Clinical Innovation
See also
References
This article is issued from Wikipedia - version of the Saturday, September 19, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.